During the past decade, Janssen Pharmaceutical K.K. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Janssen Pharmaceutical K.K." #1 collaborator was "Innovative Medicines Initiative" with 2 trials as a collaborator and "Janssen Research & Development, LLC" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Janssen Pharmaceutical K.K." are "E. Coli Infection" (1 trials) and "E.Coli Infections" (1 trials). Many other conditions were trialed in "Janssen Pharmaceutical K.K." in a lesser frequency.

The vast majority of trials in "Janssen Pharmaceutical K.K." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Janssen Pharmaceutical K.K.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Janssen Pharmaceutical K.K., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Janssen Pharmaceutical K.K., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".